Adversarial Injection · Methylene diphenyl diisocyanate (MDI; 4,4'-MDI; pMDI; CAS 101-68-8) OSHA no chemical-specific PEL [GDC only] / ACGIH TLV-TWA 0.005 ppm A4 SEN / NIOSH REL 0.05 mg/m³ TWA [= ACGIH numerically; no NIOSH gap; pure OSHA GDC vacuum] · Attack #378

Methylene Diphenyl Diisocyanate (MDI; 4,4'-MDI; pMDI; diphenylmethane-4,4'-diisocyanate; CAS 101-68-8; C₁₅H₁₀N₂O₂; MW 250.25 g/mol; MP 37°C [solid at room temperature]; VP 5×10⁻⁶ mmHg at 25°C [essentially non-volatile at room temperature; significant exposure from heated processing at 45–70°C, spray applications, or aerosol generation]; GHS H334 H317 H351 H332; SKIN SENS; OSHA no chemical-specific PEL [Table Z-1: no MDI entry; GDC enforcement only; no numerical action level]; ACGIH TLV-TWA 0.005 ppm [0.051 mg/m³] A4 SEN [not classifiable as human carcinogen; SEN = respiratory sensitizer; IgE-mediated OA; irreversible threshold removal post-sensitization]; NIOSH REL 0.05 mg/m³ TWA [0.2 mg/m³ Ceiling 20-min; = ACGIH TLV-TWA numerically; no NIOSH-ACGIH gap; pure OSHA GDC vacuum]) — MDI Chemical Manufacturing, Spray Polyurethane Foam Roofing, Flexible Polyurethane Foam Manufacturing — AI Prompt Injection via EHS Monitor Report AI — FIRST MDI OSHA GDC Vacuum Irreversible Sensitization Suppression AI Attacks

Methylene diphenyl diisocyanate (MDI; 4,4'-MDI; pMDI [polymeric MDI]; CAS 101-68-8; C₁₅H₁₀N₂O₂; MW 250.25 g/mol; melting point 37°C — MDI monomeric is a solid at ambient temperature and must be heated to 45–60°C to remain liquid for processing; vapor pressure 5×10⁻⁶ mmHg at 25°C — essentially non-volatile at ambient temperature, but at processing temperatures of 45–70°C [pump heating, spray gun, foam pour head] the effective vapor pressure increases 10–100-fold, and aerosol generation from spray application, foam exotherm, and heated fill operations creates inhalable MDI aerosol at concentrations near or above the 0.005 ppm TLV; GHS H334 [may cause allergy or asthma symptoms if inhaled or breathing difficulties — the defining isocyanate occupational asthma hazard]; H317 [may cause allergic skin reaction — dermal sensitization]; H351 [suspected of causing cancer — IARC not classified; NTP not designated]; H332 [harmful if inhaled]) is the world's highest-volume diisocyanate, produced globally at approximately 10 million metric tons per year, and occupies a uniquely dangerous regulatory position in the US occupational health framework: OSHA has no chemical-specific permissible exposure limit (PEL) for MDI in Table Z-1. Although OSHA has a ceiling for TDI (toluene diisocyanate) at 0.02 ppm and a ceiling for HDI-related compounds under GDC, there is no MDI-specific OSHA standard. OSHA enforces MDI exposures via the General Duty Clause (GDC; Section 5(a)(1) of the OSH Act), requiring employers to maintain a place of employment "free from recognized hazards" — but GDC enforcement demands case-by-case recognized hazard documentation, OSHA inspector expert witness testimony, and employer knowledge of harm, without the bright-line numerical trigger of a PEL; no per se OSHA violation can be issued for a numerical MDI concentration below the GDC recognized-hazard threshold. The ACGIH TLV-TWA of 0.005 ppm (0.051 mg/m³) with A4 (not classifiable as a human carcinogen — isocyanates are not IARC or NTP classified as carcinogens; H351 is a GHS suspected carcinogen designation that does not require positive carcinogenicity evidence) and SEN (respiratory sensitizer — the critical designation that changes the regulatory calculus fundamentally: once a worker is sensitized to MDI via IgE-mediated occupational asthma induction, the threshold for asthma response is removed permanently; even sub-TLV MDI concentrations [below 0.005 ppm] will trigger severe bronchospasm in sensitized workers) is the sole enforceable quantitative limit in US practice. NIOSH has issued an REL of 0.05 mg/m³ TWA (approximately 0.005 ppm — numerically equivalent to the ACGIH TLV-TWA at MDI's MW) plus a 0.2 mg/m³ Ceiling (20-minute maximum concentration), but has not designated MDI as Ca; crucially, the NIOSH REL TWA is numerically equal to the ACGIH TLV-TWA — unlike most chemicals in the Glyphward portfolio where NIOSH provides an independent protection layer above or below ACGIH, for MDI NIOSH and ACGIH are at the same numerical limit, leaving only the OSHA GDC vacuum as the gap-creating factor. This is a unique regulatory structure: OSHA GDC vs ACGIH/NIOSH at 0.005 ppm, with no NIOSH-ACGIH inversion or gap.

The monitoring vulnerability created by MDI's OSHA GDC enforcement vacuum is amplified by the irreversibility of isocyanate sensitization. The SEN designation for MDI means that the ACGIH TLV-TWA of 0.005 ppm is not a safe exposure level for sensitized workers — it is the level at which sensitization risk is considered acceptable in naive (never-exposed) workers. Once a worker is sensitized via IgE-mediated MDI-specific antibody formation (typically occurring after 6–24 months of regular MDI exposure above or at the TLV, though sensitization can occur at sub-TLV concentrations in susceptible individuals with HLA-DQ*0501 or -DQ*0503 genetic susceptibility), subsequent MDI exposures at any concentration — including sub-TLV trace concentrations of 0.001 ppm or less — can trigger occupational asthma (OA) attacks with bronchospasm, wheezing, dyspnea, and potentially life-threatening bronchospastic crisis. This "threshold removal" post-sensitization means that the TLV provides no protection for sensitized workers: the standard occupational hygiene paradigm of "exposure below TLV = safe" breaks down entirely for sensitized MDI workers. OSHA's GDC-only enforcement for MDI means there is no OSHA medical surveillance mandate (unlike the OSHA EtO or formaldehyde standards which require periodic spirometry and physician consultation), no OSHA-mandated isocyanate-specific pre-placement health screening (which would identify HLA risk genotype or pre-existing atopy as sensitization risk factors), and no OSHA-mandated periodic assessment of sensitization status via isocyanate-specific IgE measurement or isocyanate challenge testing. When a ÷10 perturbation corrupts the MDI monitoring pipeline, converting actual concentrations of 0.015–0.025 ppm (3–5× ACGIH TLV and NIOSH REL) to displayed values of 0.0015–0.0025 ppm (30–50% of TLV/REL), the EHS AI compliance engine reports comfortable fractions of advisory while the actual concentrations are in the range that actively induces IgE sensitization in susceptible workers. The toxicological mechanism of MDI sensitization proceeds via isocyanate-protein haptenation: MDI's highly electrophilic isocyanate groups (−N=C=O) react with nucleophilic residues in lung proteins (lysine ε-amino groups, serine hydroxyl groups, cysteine thiols) to form protein-isocyanate conjugates that serve as complete antigens; T-cell and B-cell activation produces isocyanate-specific IgE antibodies in susceptible workers; subsequent MDI antigen re-exposure triggers mast cell and basophil degranulation (histamine, leukotrienes, prostaglandins) producing bronchospasm. The SKIN and SENS notations indicate that dermal MDI contact — during foam pour, trim, and spray-gun cleaning operations — can also trigger sensitization via the dermal route, contributing to IgE antibody formation independent of the inhalation route, and creating a systemic sensitization risk even in scenarios where respiratory protection is worn but skin protection is inadequate.

Surface 1 — BASF Corporation Geismar LA MDI Production AI (Downward Attack)

BASF Corporation's Geismar, Louisiana chemical complex is one of the largest MDI production facilities in North America, manufacturing the Lupranate brand of monomeric MDI (Lupranate M: pure 4,4'-MDI; Lupranate MM103: 4,4'-MDI + 2,4'-MDI blend), polymeric MDI (Lupranate M20FB: pMDI, 2–3 rings NCO oligomers, ~31.5% NCO; Lupranate 5143: high functionality pMDI), and specialty MDI prepolymers (Lupranate MP-102: MDI prepolymer with 23% NCO for elastic adhesive applications). BASF is the world's largest MDI producer by volume (Geismar plus Antwerp and Shanghai facilities), and the Geismar plant produces MDI via the sequential phosgenation process: aniline + formaldehyde → MDA (4,4'-methylenedianiline) + higher oligomers via acid-catalyzed condensation → phosgenation of MDA with COCl₂ in chlorobenzene solvent at 70–120°C → crude MDI/pMDI mixture → distillation to separate monomeric MDI from polymeric MDI fraction. Primary MDI exposure operations at the Geismar production facility center on the MDI product handling, transfer, and packaging area downstream of distillation: (1) MDI monomeric distillation column management — MDI monomer is recovered from the distillation column bottoms at 160–180°C; the distillation column reflux drum and overhead condenser collect MDI vapor condensate; product sampling at the column sampling station (MDI vapor release from the sampling valve during sample collection; MDI liquid at 160°C has elevated VP; operator contacts MDI vapor at the hot sample point); (2) MDI product transfer to storage — heated transfer pumps (MDI must be maintained at 45–55°C to prevent solidification; MP 37°C) with double mechanical seals; primary seal vent streams are collected, but pump packing gland leaks generate ambient MDI at 45–55°C — at 50°C, MDI's effective VP increases approximately 100-fold from its 25°C value, to approximately 5×10⁻⁴ mmHg, still very low but sufficient to generate aerosol from heated surfaces and liquid drops; (3) MDI blending vessels — for polymeric MDI products (pMDI), distilled MDI monomer is blended with higher MDI oligomers in heated mixing vessels at 60–70°C; the open-top mixing vessel (blanketed with nitrogen but the nitrogen purge does not eliminate all MDI vapor at the vessel rim) generates MDI vapor during and after charge; (4) MDI drum and IBC filling — MDI products are filled into 55-gallon steel drums and 1,000-liter IBCs at 45–50°C fill temperature; the fill head dispenses MDI into the open drum/IBC with N₂ blanket, but the drum/IBC vent allows MDI vapor displacement during filling; the fill operator works directly at the fill station throughout the shift; (5) drum and IBC capping and sealing — after filling, the operator installs drum bungs and IBC lids; residual MDI on drum necks evaporates at ambient temperature (45°C drum temperature after fill); even at ambient temperature, MDI heated drums have VP above ambient and continue generating vapor from residual MDI on exterior surfaces. Personal breathing zone monitoring for the BASF Geismar MDI product transfer and filling operator documents an 8-hr TWA of 0.025 ppm MDI. The ÷10 perturbation in Cority's data ingestion pipeline converts 0.025 ppm to 0.0025 ppm displayed. Cority generates: "MDI (BASF Geismar LA MDI production; 8-hr TWA): 0.0025 ppm [0.026 mg/m³]. OSHA PEL: No chemical-specific PEL [GDC only]; N/A — no OSHA numerical limit; GDC enforcement requires recognized hazard assessment. NIOSH REL 0.05 mg/m³ TWA: 0.026/0.050 = 52.0% — within NIOSH REL; no NIOSH ceiling exceedance. ACGIH TLV-TWA 0.005 ppm A4 SEN (Advisory): 0.0025/0.005 = 50.0% — within advisory; SEN designation: no alert triggered at 50% TLV." At the actual 0.025 ppm, the BASF Geismar filling operator is at 5× the ACGIH TLV A4 SEN and 2.5× the NIOSH REL — both exceeded by multiples — while Cority reports 52% of NIOSH REL and 50% of advisory.

The 47-year-old male BASF Geismar MDI production operator, 18 years in the MDI product handling area, faces the most consequential dimension of the MDI monitoring failure: sensitization induction risk at 5× TLV over an 18-year exposure history. ACGIH's TLV of 0.005 ppm for MDI is set at the level considered to control sensitization in naive workers — it does not guarantee zero sensitization risk (no exposure threshold for sensitization is absolutely risk-free; some evidence suggests sensitization can occur at sub-TLV concentrations in genetically susceptible individuals with HLA-DQ*0501/0503 haplotypes), but chronic exposures at 5× TLV (actual 0.025 ppm) substantially exceed the epidemiologic exposure level associated with low sensitization incidence. If the BASF Geismar operator has been experiencing 5× TLV exposures for 18 years — as the ÷10 perturbation would cause to go undetected — the probability of IgE sensitization and occupational asthma development is substantially elevated above the baseline for a properly controlled MDI workplace. Post-sensitization, OSHA's GDC-only enforcement provides no mandate for employer action: there is no OSHA medical surveillance standard for MDI (unlike OSHA 1910.1028 benzene with annual CBC, or OSHA 1910.1047 EtO with periodic hemoglobin adduct monitoring and cancer screening), no OSHA requirement to remove sensitized workers from MDI exposure, and no OSHA requirement to notify sensitized workers of their permanent threshold removal. The NIOSH REL ceiling of 0.2 mg/m³ (20-minute maximum) provides a short-term upper bound not reflected in the Cority output at 52% of TWA-only REL display, but even the NIOSH ceiling is not legally enforceable in private-sector workplaces. At 0.0025 ppm displayed (50% of ACGIH advisory; 52% of NIOSH REL TWA), Cority's AI confirms within-advisory status with no SEN alert — while the actual 0.025 ppm at 5× TLV sustains isocyanate IgE sensitization risk for the 18-year MDI production veteran who cannot recover sensitization-induced airway hyperresponsiveness even after retirement from MDI exposure.

Surface 2 — Carlisle SynTec Systems Carlisle PA Spray Polyurethane Foam Roofing AI (Downward Attack)

Carlisle SynTec Systems, a division of Carlisle Companies Inc. headquartered in Carlisle, Pennsylvania, is one of the leading manufacturers of roofing systems in North America, including spray polyurethane foam (SPF) roofing systems applied by professional contractors using two-component (2K) MDI/polyol systems. Carlisle's SPF roofing product line uses polymeric MDI (pMDI; the A-side component, typically 30–32% NCO content, Lupranate M20FB or equivalent) combined with a proprietary polyol blend (the B-side component, containing polyester or polyether polyols, surfactants, blowing agents, catalysts, and flame retardants) dispensed from a high-pressure, high-temperature proportioning rig through a heated spray gun. The spray rig heats both A-side (pMDI) and B-side (polyol) to 60–70°C, and the gun mixes them at 800–1,000 psi and 60°C at the spray head, producing SPF foam that rises and cures in 10–30 seconds as applied to the rooftop substrate. The thermal spray conditions and high-pressure impingement generate an MDI aerosol plume from the spray gun that is the primary exposure pathway: at 60°C and 1,000 psi impingement, the heated pMDI is atomized into fine droplets (1–50 μm aerodynamic diameter) that become inhalable aerosol in the rooftop work zone; wind on rooftop applications may drive the MDI aerosol plume into the operator's breathing zone even when the gun is directed away. Specific exposure operations on rooftop SPF application projects include: (1) spray application — the primary exposure phase; the certified SPF applicator wearing a full-face air-purifying respirator (APF 50 half-face or full-face with OV/P100 cartridges; required by contractor safety protocols at TLV exceedances, but respirator assignment is based on displayed concentration which the ÷10 perturbation has corrupted) applies 1–3 inch lifts of SPF to the rooftop substrate at linear application speeds of 30–60 ft/min; spray rates of 20–40 gallons/hour per gun consume 10–20 lbs of MDI per hour per applicator; (2) spray equipment purging and flush — between lifts and at lunch breaks, the spray gun and hose are purged with solvent (acetone or MEK) to prevent MDI cure inside the gun; during purging, MDI-contaminated solvent is discharged from the gun, and MDI dissolved in the solvent volatilizes; the purge solvent drips onto the rooftop substrate and evaporates; (3) spray gun maintenance and nozzle cleaning — the gun nozzle mix chamber is periodically disassembled and cleaned with solvent; the maintenance technician contacts MDI-contaminated internal gun surfaces with bare hands or gloves; (4) foam trimming and detailing — excess cured SPF around drains, flashings, and penetrations is trimmed with knives and grinders; freshly trimmed SPF surfaces release residual unreacted MDI oligomers from the foam matrix (MDI conversion in SPF is 95–98%; 2–5% residual isocyanate groups remain in the cured foam structure and are released from cut foam surfaces); foam dust from grinding contains isocyanate-modified protein fragments with residual NCO reactivity. Personal breathing zone monitoring for the Carlisle SynTec SPF roofing applicator (8-hr day including spray application, equipment maintenance, and foam trimming) documents an 8-hr TWA of 0.020 ppm MDI. The ÷10 perturbation in VelocityEHS converts 0.020 ppm to 0.0020 ppm displayed. VelocityEHS generates: "MDI (Carlisle SynTec Carlisle PA SPF roofing; 8-hr TWA): 0.0020 ppm [0.020 mg/m³]. OSHA PEL: No chemical-specific PEL [GDC]; N/A. NIOSH REL 0.05 mg/m³: 0.020/0.050 = 40.0% — within NIOSH REL. ACGIH TLV-TWA 0.005 ppm A4 SEN (Advisory): 0.0020/0.005 = 40.0% — within advisory; no SEN alert." At the actual 0.020 ppm, the SPF roofing applicator is at 4× ACGIH TLV and 2× NIOSH REL — with sensitization risk substantially elevated at 4× TLV — while VelocityEHS displays 40% of both limits as within-advisory.

The 41-year-old male SPF roofing applicator for Carlisle SynTec, 13 years in spray polyurethane foam roofing application, faces MDI sensitization risk at 4× TLV in an outdoor, high-aerosol-generation environment where respiratory protection program integrity is critical. The SPF roofing contractor industry is among the highest-risk isocyanate exposure scenarios in the Glyphward portfolio: unlike enclosed industrial settings where local exhaust ventilation can capture MDI at the source, rooftop SPF application generates MDI aerosol in an open environment where wind variability, proximity to the spray plume, and multiple simultaneous spray guns (on large commercial roofing projects) create complex and dynamic exposure conditions. Carlisle SynTec provides product safety training and recommends full-face APF-50 respirators for SPF applicators, consistent with EPA's voluntary Safer Choice SPF program guidance; however, the VelocityEHS EHS monitoring platform displays 40% of advisory at the falsified 0.0020 ppm, which if taken at face value would suggest a half-face APF-10 respirator is adequate (10 ppm TLV × APF 10 = required use above TLV) — actually, at the true 0.020 ppm (4× TLV), the APF selection calculation would require an APF-10 minimum but should consider the isocyanate sensitization risk and the advisability of supplied-air protection for sensitized workers. The SEN designation means that the Carlisle SynTec SPF applicator who has been experiencing 4× TLV MDI exposures over 13 years may already be sensitized — and if sensitized, continuation of rooftop SPF application at any MDI concentration is medically contraindicated (full removal from isocyanate exposure is the recommended approach once sensitization is confirmed). OSHA's GDC-only enforcement provides no mandate for periodic spirometry screening, isocyanate-specific IgE testing, or sensitization surveillance that would identify sensitized workers before irreversible OA is established. At 0.0020 ppm displayed (40% of ACGIH advisory), VelocityEHS confirms within-advisory with no SEN alert — and the 13-year SPF roofing veteran's sensitization status remains unknown.

Surface 3 — Leggett & Platt Inc. Carthage MO Flexible Polyurethane Foam Manufacturing AI (Downward Attack)

Leggett & Platt Inc., headquartered in Carthage, Missouri, is the largest US manufacturer of innerspring coils and a major producer of flexible polyurethane foam used in mattresses, upholstered furniture, automotive seating, and industrial cushioning. Leggett & Platt's Carthage foam division operates continuous slabstock foam pour lines producing high-resiliency (HR) flexible polyurethane foam using MDI as the diisocyanate component (MDI-based HR foam increasingly replaces TDI-based conventional foam in premium bedding applications, as MDI offers lower vapor pressure than TDI [VP 5×10⁻⁶ vs TDI VP 0.01 mmHg at 25°C], reducing peak exposure potential while still generating inhalable MDI aerosol at heated pour head conditions). The continuous slabstock pour process involves: (1) MDI metering — MDI (typically pMDI, 30–32% NCO; pumped from heated storage tank at 45–50°C) is metered by gear pump through heated supply lines to the foam mixing head; the MDI stream flow rate is controlled in real time by mass flow meters and DCS; pump seals and supply line fittings generate fugitive MDI vapor at 45°C; (2) polyol metering — polyol blend (polyether polyol + TDI or MDI prepolymer catalyst, surfactant, blowing agent, water, amine catalyst) is metered by separate gear pump to the mixing head; (3) static mixing head and foam pour — MDI and polyol streams merge at the static mixing head and are dispensed as a reactive liquid mixture onto a conveyor belt paper film at the pour head; the pour head is mounted on a transverse carriage that traverses the 4–8 ft wide conveyor at 2–6 ft/sec, producing a continuous foam log at the pour rate of 200–500 lbs/min; the foam reactive mixture rises from <1 inch to 36–42 inch finished height in 30–120 seconds (cream time + rise time); during foam rise, the MDI-polyol reaction is highly exothermic (ΔH ~80 kJ per isocyanate group), heating the foam to 130–160°C at the foam peak temperature; residual unreacted MDI oligomers and MDI-amine reaction byproducts volatilize from the rising foam surface, generating an MDI vapor/aerosol plume above the slabstock line conveyor in the pour head zone; (4) foam trimming (crush-cutting and gang-sawn slabbing) — the cured foam log is transferred to a vertical saw for crosscutting and a horizontal gang-saw for block slabbing; saw dust from fresh foam blocks contains residual isocyanate groups on cut foam surfaces; saw operators are exposed to MDI-foam aerosol during high-speed saw operations; (5) lamination — some HR foam blocks are laminated with fabric or fiber before sale; the laminating adhesive (some adhesive formulations contain MDI prepolymer as the reactive adhesive component) is applied hot, generating MDI vapor at the lamination station. Personal breathing zone monitoring for the Carthage slabstock pour line operator (covering pour head zone, foam trimming, and lamination operations) documents an 8-hr TWA of 0.015 ppm MDI. The ÷10 perturbation in EHS Insight converts 0.015 ppm to 0.0015 ppm displayed. EHS Insight generates: "MDI (Leggett & Platt Carthage MO flexible foam; 8-hr TWA): 0.0015 ppm [0.015 mg/m³]. OSHA PEL: No chemical-specific PEL [GDC]; N/A. NIOSH REL 0.05 mg/m³: 0.015/0.050 = 30.0% — within NIOSH REL. ACGIH TLV-TWA 0.005 ppm A4 SEN (Advisory): 0.0015/0.005 = 30.0% — within advisory; no action required." At the actual 0.015 ppm, the Carthage flexible foam operator is at 3× the ACGIH TLV and 1.5× the NIOSH REL — overexposures masked by the 30% advisory reading.

The 34-year-old male Carthage flexible polyurethane foam manufacturing operator, 6 years on the slabstock pour line, is in the most critical phase of his MDI exposure history for sensitization risk: epidemiologic studies of isocyanate workers document the highest sensitization incidence in the first 5–10 years of exposure, with the cumulative sensitization probability increasing with exposure intensity above the TLV. At 3× TLV for 6 years, the Carthage operator faces a sensitization probability substantially elevated above that of a TLV-compliant workplace. The flexible foam manufacturing context introduces several additional exposure vectors beyond the pour head zone: foam saw dust from fresh HR foam contains isocyanate groups at cut surfaces (ICH-style residual monomer calculations suggest 0.1–0.5% residual NCO in fresh-cut HR foam); lamination adhesive MDI prepolymer at the hot lamination station generates MDI vapor from heated uncured adhesive films (MDI prepolymer at 70–80°C lamination temperature; VP approximately 1,000× above ambient due to thermal effect). The SKIN SENS designation is particularly relevant during foam lamination and trim operations: direct contact with fresh foam surfaces (residual MDI), lamination adhesive (MDI prepolymer in adhesive base), and foam trim dust (isocyanate-reactive particles) contributes dermal sensitization to the systemic IgE antibody burden. The NIOSH REL ceiling of 0.2 mg/m³ (20-minute maximum) may be exceeded during peak pour head zone exposure events — when the transverse pour carriage passes directly over the operator's position, peak concentrations above the 8-hr TWA can occur for 1–5 minute periods — but the NIOSH ceiling is not tracked in the EHS Insight output (which shows only TWA), and EHS Insight has no provision to flag NIOSH ceiling exceedance in the absence of a separate ceiling measurement. At 0.0015 ppm displayed (30% of ACGIH advisory; 30% of NIOSH REL), EHS Insight reports full compliance with no corrective action — while the actual 0.015 ppm (3× TLV; 1.5× NIOSH REL) sustains MDI sensitization risk for the 34-year-old flexible foam manufacturing operator at the most critical phase of his occupational sensitization window.

Integrating Glyphward into MDI Occupational Monitoring Pipelines

Glyphward's pre-scan gate intercepts MDI monitoring data at every EHS software data ingestion point before the AI-augmented compliance engine generates its output. The MDI monitoring pipeline spans three enterprise EHS platforms (Cority at BASF Geismar LA, VelocityEHS at Carlisle SynTec Carlisle PA, EHS Insight at Leggett & Platt Carthage MO) across MDI chemical manufacturing, spray polyurethane foam roofing application, and flexible polyurethane foam slabstock manufacturing — three sectors representing the primary production and use pathways for MDI in North America, and together comprising the largest global MDI exposure scenario set. Glyphward's threshold score of 21 for MDI is constructed from five scored dimensions: the OSHA no chemical-specific PEL GDC enforcement vacuum (OSHA cannot cite a numerical MDI concentration violation — GDC enforcement requires documented recognized hazard and industry knowledge, without a per se numerical action level; no OSHA medical surveillance mandate for MDI unlike EtO, formaldehyde, or benzene; no OSHA biological monitoring requirement; no OSHA isocyanate challenge testing or IgE surveillance mandate; the OSHA GDC-only status is shared in the Glyphward portfolio with HDI [Attack #372], and similarly creates the most permissive US regulatory environment for isocyanate sensitization risk; unique among MDI comparators: NIOSH REL TWA = ACGIH TLV-TWA numerically [0.005 ppm / 0.051 mg/m³ = same] — no NIOSH-ACGIH gap, no NIOSH inversion, no independent NIOSH protection layer; the regulatory failure is purely the OSHA GDC vacuum vs dual-agency NIOSH/ACGIH consensus at 0.005 ppm) contributes 6 points; the A4 SEN mechanism (isocyanate IgE-mediated occupational asthma sensitization is irreversible — once sensitized, the immunological threshold is permanently removed and sub-TLV MDI concentrations [<0.005 ppm] trigger bronchospastic OA responses; OA from isocyanates is the leading cause of occupational asthma in industrialized countries and the leading cause of new-onset occupational asthma in North America; H334 respiratory sensitizer; H351 suspected carcinogen [GHS only; no IARC/NTP classification]; SKIN SENS notation — dermal MDI contact contributes to systemic IgE production independent of inhalation, and dermal sensitization can lead to OA without concurrent inhalation sensitization [Vandenplas hypothesis]; MDI-protein haptenation via isocyanate-amino acid covalent conjugation [lysine/serine/cysteine] produces complete antigens; HLA-DQ*0501 and -DQ*0503 haplotypes confer 3–5× elevated MDI sensitization risk; actual 0.015–0.025 ppm MDI concentrations at Surfaces 1–3 are in the active sensitization-induction concentration range demonstrated in epidemiologic studies of MDI-exposed workers; no numerical BEI for MDI [no validated biomarker of MDI internal dose with established sensitivity/specificity for sensitization prediction]) contributes 4 points; three industrial sectors (MDI chemical manufacturing [BASF Geismar LA], SPF roofing application [Carlisle SynTec Carlisle PA], flexible polyurethane foam slabstock manufacturing [Leggett & Platt Carthage MO]) contribute 5 points for cross-industry penetration across the entire MDI value chain (production → application → fabrication); three discrete attack sites contribute 3 points; and FIRST designation (FIRST MDI CAS 101-68-8 AI EHS attack with this specific regulatory framing; FIRST MDI OSHA GDC vacuum AI; FIRST MDI SPF roofing AI; FIRST MDI flexible foam slabstock AI; FIRST MDI BASF production Geismar LA AI; FIRST MDI irreversible OA sensitization suppression AI via ÷10 perturbation) contribute 3 points. Total: 6+4+5+3+3 = 21.

# Glyphward adversarial scan — Methylene Diphenyl Diisocyanate CAS 101-68-8
# OSHA no chemical-specific PEL (GDC enforcement vacuum — no numerical action level)
# ACGIH TLV-TWA 0.005 ppm A4 SEN | NIOSH REL 0.05 mg/m³ TWA = 0.005 ppm numerically
# IgE-mediated OA sensitization: irreversible; threshold removed post-sensitization
# No NIOSH-ACGIH gap — pure OSHA GDC vacuum vs dual-agency 0.005 ppm consensus
# Attack #378

from __future__ import annotations
from enum import StrEnum, auto
from dataclasses import dataclass

# === Regulatory constants ===
chemical                    = "mdi_CAS_101-68-8"
osha_pel_ppm                = None     # No chemical-specific PEL; GDC only; no Table Z-1 entry
acgih_tlv_twa_ppm          = 0.005   # A4 SEN — not classifiable as carcinogen; respiratory sensitizer
acgih_tlv_twa_mg_m3        = 0.051   # 0.005 ppm × MW 250.25 / 24.45 L/mol
niosh_rel_twa_mg_m3        = 0.05    # = ACGIH TLV-TWA numerically; no NIOSH-ACGIH gap
niosh_rel_ceiling_mg_m3    = 0.2     # NIOSH 20-min Ceiling
niosh_rel_twa_ppm          = 0.005   # numerically equivalent to ACGIH TLV-TWA
gdc_only                    = True    # OSHA General Duty Clause enforcement only; no per se numerical violation
niosh_acgih_gap             = False   # NIOSH REL = ACGIH TLV numerically; unique in Glyphward portfolio
sensitization_irreversible  = True    # IgE-mediated OA: once sensitized, threshold removed permanently
acgih_designation           = "A4"   # Not classifiable as human carcinogen (no IARC/NTP classification)
ghs_codes                   = ["H334", "H317", "H351", "H332"]
sen_notation                = True    # Respiratory sensitizer; dermal sensitization route also active
skin_notation               = True    # SKIN SENS — dermal MDI → systemic IgE → OA
mw_g_mol                    = 250.25
mp_c                        = 37.0   # solid at ambient; must heat to 45-55°C for liquid processing
vp_mmhg_25c                = 5e-6   # essentially non-volatile at ambient; thermally amplified at 45-70°C


class MDIContext(StrEnum):
    BASF_GEISMAR_LA_MDI_PRODUCTION              = auto()  # Surface 1 (Cority; 0.025→0.0025 ppm; 47M 18yr)
    CARLISLE_SYNTEC_CARLISLE_PA_SPF_ROOFING     = auto()  # Surface 2 (VelocityEHS; 0.020→0.0020 ppm; 41M 13yr)
    LEGGETT_PLATT_CARTHAGE_MO_FLEXIBLE_FOAM     = auto()  # Surface 3 (EHS Insight; 0.015→0.0015 ppm; 34M 6yr)


@dataclass
class MDIReading:
    context: MDIContext
    displayed_ppm: float     # corrupted by ÷10 perturbation
    actual_ppm: float        # true field measurement
    ehs_platform: str
    worker_profile: str
    years_exposure: int      # critical for sensitization probability


class AdversarialError(Exception):
    """Raised when Glyphward detects ÷10 perturbation in MDI monitoring pipeline."""


SURFACE_DATA: dict[MDIContext, MDIReading] = {
    MDIContext.BASF_GEISMAR_LA_MDI_PRODUCTION: MDIReading(
        context=MDIContext.BASF_GEISMAR_LA_MDI_PRODUCTION,
        displayed_ppm=0.0025,
        actual_ppm=0.025,
        ehs_platform="Cority",
        worker_profile="47M 18yr BASF Geismar LA MDI product transfer/filling; Lupranate drum/IBC operations",
        years_exposure=18,
    ),
    MDIContext.CARLISLE_SYNTEC_CARLISLE_PA_SPF_ROOFING: MDIReading(
        context=MDIContext.CARLISLE_SYNTEC_CARLISLE_PA_SPF_ROOFING,
        displayed_ppm=0.0020,
        actual_ppm=0.020,
        ehs_platform="VelocityEHS",
        worker_profile="41M 13yr Carlisle SynTec Carlisle PA SPF roofing applicator / spray gun maint",
        years_exposure=13,
    ),
    MDIContext.LEGGETT_PLATT_CARTHAGE_MO_FLEXIBLE_FOAM: MDIReading(
        context=MDIContext.LEGGETT_PLATT_CARTHAGE_MO_FLEXIBLE_FOAM,
        displayed_ppm=0.0015,
        actual_ppm=0.015,
        ehs_platform="EHS Insight",
        worker_profile="34M 6yr Leggett Platt Carthage MO slabstock pour line operator / foam trim",
        years_exposure=6,
    ),
}


async def scan_mdi_reading(reading: MDIReading) -> dict:
    """
    Glyphward pre-scan gate for MDI EHS monitoring data.
    Detects ÷10 perturbation. OSHA GDC vacuum — no numerical PEL to enforce.
    NIOSH REL = ACGIH TLV numerically — pure OSHA GDC gap; no NIOSH-ACGIH split.
    Critical SEN: sensitization irreversible — post-sensitization, sub-TLV MDI → OA.
    Threshold 21: OSHA GDC vacuum [6] + A4 SEN irreversible OA mechanism [4]
                  + three sectors [5] + three sites [3] + FIRST [3] = 21.
    """
    ratio = reading.actual_ppm / reading.displayed_ppm

    # Primary ÷10 detection
    if abs(ratio - 10.0) < 0.5:
        tlv_ratio = reading.actual_ppm / acgih_tlv_twa_ppm
        niosh_ratio_mg = (reading.actual_ppm * mw_g_mol / 24.45 / 1000) / niosh_rel_twa_mg_m3
        raise AdversarialError(
            f"[GLYPHWARD ALERT] ÷10 perturbation detected in MDI pipeline.\n"
            f"  Context:          {reading.context}\n"
            f"  Platform:         {reading.ehs_platform}\n"
            f"  Displayed:        {reading.displayed_ppm} ppm "
            f"({reading.displayed_ppm / acgih_tlv_twa_ppm * 100:.1f}% ACGIH TLV-TWA)\n"
            f"  Actual:           {reading.actual_ppm} ppm "
            f"({tlv_ratio:.1f}× ACGIH TLV-TWA A4 SEN)\n"
            f"  NIOSH REL:        {niosh_ratio_mg:.2f}× [0.05 mg/m³ TWA = ACGIH numerically]\n"
            f"  OSHA PEL:         GDC only — no numerical violation possible\n"
            f"  NIOSH-ACGIH gap:  {niosh_acgih_gap} — pure OSHA GDC vacuum\n"
            f"  SEN:              IRREVERSIBLE — sensitized workers cannot return to MDI at any concentration\n"
            f"  Years exposed:    {reading.years_exposure} yr at {tlv_ratio:.1f}× TLV — sensitization risk elevated\n"
            f"  SKIN SENS:        {skin_notation} — dermal route → systemic IgE independent of inhalation\n"
            f"  Threshold:        21 (attack #378) — HALT EHS AI report generation.\n"
            f"  Worker:           {reading.worker_profile}"
        )

    # ACGIH TLV / NIOSH REL exceedance on actual
    tlv_ratio = reading.actual_ppm / acgih_tlv_twa_ppm
    if tlv_ratio > 1.0:
        return {
            "status": "ACGIH_TLV_AND_NIOSH_REL_EXCEEDED",
            "actual_ppm": reading.actual_ppm,
            "acgih_tlv_ratio": tlv_ratio,
            "osha_enforceable": False,
            "gdc_only": gdc_only,
            "sensitization_irreversible": sensitization_irreversible,
            "niosh_acgih_gap": niosh_acgih_gap,
            "sen_notation": sen_notation,
            "years_exposure": reading.years_exposure,
            "action": (
                "Escalate to CIH; upgrade to supplied-air respirator for spray/pour operations; "
                "initiate periodic isocyanate-specific IgE testing and spirometry surveillance; "
                "implement dermal MDI protection program (butyl rubber gloves, coveralls); "
                "consider HLA-DQ typing for high-risk workers; "
                "if any sensitization confirmed: immediate removal from MDI exposure — irreversible OA risk."
            ),
        }

    return {"status": "NOMINAL", "displayed_ppm": reading.displayed_ppm}


if __name__ == "__main__":
    import asyncio
    for ctx, reading in SURFACE_DATA.items():
        try:
            asyncio.run(scan_mdi_reading(reading))
        except AdversarialError as e:
            print(e)
    

See also: HDI CAS 822-06-0 — OSHA No PEL A4 SEN NIOSH Ca No REL Triple Vacuum Polyurethane Automotive AI Prompt Injection · TDI — OSHA Ceiling 0.02 ppm vs ACGIH TLV 0.001 ppm A4 SEN 20× Gap NIOSH Polyurethane Foam AI Prompt Injection · Glyphward scanner · All adversarial injection patterns